Buy These 5 Dividend Growth Stocks Amid Conflicting Labor Market Data

U.S. December jobs data presented a mixed signal—unemployment ticked down to 4.4% (better than expectations) while payrolls growth missed estimates and fell from November—helping U.S. indices close higher on Jan. 9, 2026. In response, the note highlights a tactical shift toward dividend-growth stocks as a defensive play and lists five Zacks-screened names with supporting metrics: Woodward (WWD) — fiscal 2026 revenue est. +11.2%, long-term EPS growth 15.2%, yield 0.35%, Zacks Rank 2 Growth A; Cardinal Health (CAH) — fiscal 2026 revenue est. +16.2%, LT EPS 13.9%, yield 1.02%, Rank 2 Growth A; Fox (FOX) — fiscal 2027 revenue est. +3.6%, LT EPS 10.1%, yield 0.84%, Rank 2 Growth B; Kinross Gold (KGC) — 2026 revenue est. +11%, LT EPS 36.5%, yield 0.45%, Rank 1 Growth A; Donaldson (DCI) — fiscal 2026 revenue est. +3.5%, LT EPS 10%, yield 1.26%, Rank 2 Growth B.

Analysis

Market structure: The mixed December jobs print (unemployment 4.4% but payrolls miss) favors higher-quality, dividend-growth names as equity volatility rises and growth narratives weaken. Expect a modest risk-off tilt over 1–3 months: flows into defensive sectors (healthcare, consumer staples, select industrials) and gold miners (KGC) while high-multiple tech weakens; corporate bond spreads may tighten slightly if Fed pause narratives firm, but real yields remain the swing factor.

Risk assessment: Key tail risks include an upside inflation surprise that forces renewed Fed hikes (real yields +50–100bps) that would punish dividend growth and gold, and a sharper-than-expected economic slowdown that forces dividend cuts (watch payout ratios >60%). Immediate (days): headlines/CPI/Fed speak move flows; short-term (weeks–months): earnings and cash-flow revisions; long-term (12–24 months): balance-sheet resilience and free-cash-flow trends determine survivors.

Trade implications: Favor 3–12 month plays on CAH, DCI, KGC and selective industrials (WWD) with active risk management: use covered calls to monetize lower volatility in dividend stocks and call spreads on KGC to lever a gold rally if real rates fall. Consider pair trades: long CAH/DCI vs short high-valuation growth (reduce QQQ-ish exposures) to express quality-over-growth.

Contrarian angles: Consensus underestimates earnings vulnerability—dividend-growth lists mask operational cyclicality (WWD tied to aerospace OEM cycles). The market may underprice the downside for commodity-linked miners if US growth stabilizes; KGC could be overbought on a technical reflex rally, so scale in on 5–10% pullbacks and watch real-rate moves closely.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in CAH (Cardinal Health) over 3–12 months; target +15–20% upside if FY26 revenue / EPS revisions hold, set a protective stop-loss at -10% or trim if payout ratio moves above 55% or next quarter guidance misses by >5%.
• Initiate a 1.5–2% tactical position in KGC (Kinross) as a hedge against falling real rates over 6–9 months: prefer 6–9 month call spreads (debit-limited) sized to equal cash exposure; add another 1% on a pullback ≥8% or if 10-year real yield falls >50bps from current levels.
• Overweight DCI (Donaldson) at 1.5–2% and implement a 30–60 day covered-call program to boost yield (sell OTM calls to generate 2–4% quarterly income); reduce cyclicality risk by trimming WWD exposure if aerospace OEM backlogs drop by >10% sequentially.
• Reduce high-valuation growth beta by 20–30% of current exposure within 1–2 weeks (e.g., rotate from QQQ/mega-cap growth) and redeploy proceeds into the above dividend-growth names; reassess after next two CPI prints and the Fed's January meeting minutes.